Serum gonadal hormones levels and hypogonadism in ART naïve newly diagnosed HIV infected adult males in Mwanza, Tanzania.
Antiretroviral naïve males
Gonadal hormones
Human immunodeficiency virus
Hypogonadism
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
received:
05
05
2023
accepted:
15
04
2024
medline:
24
4
2024
pubmed:
24
4
2024
entrez:
23
4
2024
Statut:
epublish
Résumé
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is an endemic chronic disease which is characterized with progressive depletion of CD4 T cells and increased susceptibility to opportunistic infections. Previous studies have associated HIV infection with increased hypogonadism. However, the prevalence of hypogonadism remained poorly defined and widely ranging in various studies. This study aims to evaluate the serum gonadal hormonal levels and hypogonadism in antiretroviral therapy (ART) naïve newly diagnosed HIV infected-males in Mwanza, Tanzania. This was a comparison study involving 81 ART naïve newly diagnosed HIV-infected adult males as study group and 81 apparently healthy HIV-negative males as comparison group. The participants in the study group and comparison group were matched by body mass index and age. Serum hormones [Total testosterone (TT), follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E) were estimated. Serum testosterone < 300 ng/dl, or testosterone > 300 ng/dl with high LH and FSH (compensatory hypogonadism) were taken as markers of hypogonadism. Data were analyzed using STATA version 15. The median serum testosterone level among ART naïve newly diagnosed HIV-infected adult males was significantly lower as compared to their comparison group (447 [259-534] versus 517 [396-605]; p = 0.0074) and shown to decrease with decreasing CD4 level. The median [IQR] serum FSH level among ART naïve newly diagnosed HIV-infected adult males was significantly higher than among their comparison group (3.8 [2.1-6.5] versus 2.6 [1.8-4.2]; p = 0.0086). The differences in serum LH and Estradiol were not statistically significant. Furthermore, the proportion of hypogonadism was significantly higher among ART naïve newly diagnosed HIV-infected adult males than in their comparison group (37.0% [30/81] versus 14.8% [12/81]; p = 0.0006). Out of these 30, 24 HIV-infected males had secondary hypogonadism, one had primary, and the remaining five had compensatory hypogonadism. Serum testosterone was lower and follicle stimulating hormone was higher among ART naïve HIV-infected males as compared to the HIV negative controls. Hypogonadism, mainly secondary, is common endocrine abnormality among ART naïve HIV-infected male patients in this study. HIV is associated with variations in gonadal hormones which may lead to sexual dysfunction in infected individuals.
Sections du résumé
BACKGROUND
BACKGROUND
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is an endemic chronic disease which is characterized with progressive depletion of CD4 T cells and increased susceptibility to opportunistic infections. Previous studies have associated HIV infection with increased hypogonadism. However, the prevalence of hypogonadism remained poorly defined and widely ranging in various studies. This study aims to evaluate the serum gonadal hormonal levels and hypogonadism in antiretroviral therapy (ART) naïve newly diagnosed HIV infected-males in Mwanza, Tanzania.
METHODS
METHODS
This was a comparison study involving 81 ART naïve newly diagnosed HIV-infected adult males as study group and 81 apparently healthy HIV-negative males as comparison group. The participants in the study group and comparison group were matched by body mass index and age. Serum hormones [Total testosterone (TT), follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E) were estimated. Serum testosterone < 300 ng/dl, or testosterone > 300 ng/dl with high LH and FSH (compensatory hypogonadism) were taken as markers of hypogonadism. Data were analyzed using STATA version 15.
RESULTS
RESULTS
The median serum testosterone level among ART naïve newly diagnosed HIV-infected adult males was significantly lower as compared to their comparison group (447 [259-534] versus 517 [396-605]; p = 0.0074) and shown to decrease with decreasing CD4 level. The median [IQR] serum FSH level among ART naïve newly diagnosed HIV-infected adult males was significantly higher than among their comparison group (3.8 [2.1-6.5] versus 2.6 [1.8-4.2]; p = 0.0086). The differences in serum LH and Estradiol were not statistically significant. Furthermore, the proportion of hypogonadism was significantly higher among ART naïve newly diagnosed HIV-infected adult males than in their comparison group (37.0% [30/81] versus 14.8% [12/81]; p = 0.0006). Out of these 30, 24 HIV-infected males had secondary hypogonadism, one had primary, and the remaining five had compensatory hypogonadism.
CONCLUSION
CONCLUSIONS
Serum testosterone was lower and follicle stimulating hormone was higher among ART naïve HIV-infected males as compared to the HIV negative controls. Hypogonadism, mainly secondary, is common endocrine abnormality among ART naïve HIV-infected male patients in this study. HIV is associated with variations in gonadal hormones which may lead to sexual dysfunction in infected individuals.
Identifiants
pubmed: 38654196
doi: 10.1186/s12902-024-01581-w
pii: 10.1186/s12902-024-01581-w
doi:
Substances chimiques
Testosterone
3XMK78S47O
Luteinizing Hormone
9002-67-9
Follicle Stimulating Hormone
9002-68-0
Gonadal Hormones
0
Estradiol
4TI98Z838E
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Informations de copyright
© 2024. The Author(s).
Références
Amegor O, Bigila D, Oyesola O, Oyesola T, Buseni S. Hematological changes in HIV patients placed on anti retroviral therapy in Markurdi, Benue State of Nigeria. Asian J Epidemiol. 2009;2(4):97–103.
doi: 10.3923/aje.2009.97.103
World Health Organization. UNAIDS: Global HIV and AIDS statistics– 2023 fact sheets. Available from: www.unaidsorg/en/resources/fact-sheet2023 .
Ashwood ER, Bruns DE. Tietz fundamentals of clinical chemistry. Saunders Elsevier; 2008.
Sinha U, Sengupta N, Mukhopadhyay P, Roy KS. Human immunodeficiency virus endocrinopathy. Indian J Endocrinol Metabol. 2011;15(4):251.
doi: 10.4103/2230-8210.85574
Bhasin S, Singh AB, Javanbakht M. Neuroendocrine abnormalities associated with HIV infection. Endocrinol Metab Clin North Am. 2001;30(3):749–64.
pubmed: 11571939
doi: 10.1016/S0889-8529(05)70210-3
Meena L, Rai M, Singh S, Chakravarty J, Singh A, Goel R, Pathak A, Sundar S. Endocrine changes in male HIV patients. JAPI. 2011;59:1–3.
Post F, Soule S, Willcox P, Levitt N. The spectrum of endocrine dysfunction in active pulmonary tuberculosis. Clin Endocrinol. 1994;40(3):367–71.
doi: 10.1111/j.1365-2265.1994.tb03933.x
Kaplan F, Levitt N, Soule S. Primary hypoadrenalism assessed by the 1 µg ACTH test in hospitalized patients with active pulmonary tuberculosis. QJM. 2000;93(9):603–9.
pubmed: 10984555
doi: 10.1093/qjmed/93.9.603
Villette J, Bourin P, Doinel C, Mansour I, Fiet J, Boudou P, Dreux C, Roue R, Debord M, Levi F. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metabolism. 1990;70(3):572–7.
doi: 10.1210/jcem-70-3-572
Punjani N, Nayan M, Jarvi K, Lo K, Lau S, Grober ED. The effect of ethnicity on semen analysis and hormones in the infertile patient. Can Urol Association J. 2020;14(2):31.
Hu H, Odedina FT, Reams RR, Lissaker CT, Xu X. Racial differences in age-related variations of testosterone levels among US males: potential implications for prostate cancer and personalized medication. J Racial Ethnic Health Disparities. 2015;2(1):69–76.
doi: 10.1007/s40615-014-0049-8
Richard A, Rohrmann S, Zhang L, Eichholzer M, Basaria S, Selvin E, Dobs AS, Kanarek N, Menke A, Nelson WG. Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis. Andrology. 2014;2(3):428–35.
pubmed: 24648111
pmcid: 4327897
doi: 10.1111/j.2047-2927.2014.00206.x
Lopez DS, Peskoe SB, Joshu CE, Dobs A, Feinleib M, Kanarek N, Nelson WG, Selvin E, Rohrmann S, Platz EA. Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males. Cancer Causes Control. 2013;24(4):817–26.
pubmed: 23354421
doi: 10.1007/s10552-013-0154-8
Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis. 2005;41(12):1794–803.
pubmed: 16288406
doi: 10.1086/498311
Guzzo KB, Nash SP, Manning WD, Longmore MA, Giordano PC. Unpacking the black box of race–ethnic variation in fertility. Race Social Probl. 2015;7(2):135–49.
doi: 10.1007/s12552-014-9141-2
Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet. 2009;18(19):3749–57.
pubmed: 19574343
pmcid: 2742399
doi: 10.1093/hmg/ddp302
Kirkwood BR, Sterne JA. Medical statistics. Medical statistics 2003.
Bajaj S, Pathak Y, Varma S, Verma S. Metabolic status and hypogonadism in human immunodeficiency virus-infected males. Indian J Endocrinol Metabol. 2017;21(5):684.
doi: 10.4103/ijem.IJEM_127_17
Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C, Carli F, Carani C, Guaraldi G. Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS ONE. 2011;6(12):e28512.
pubmed: 22174826
pmcid: 3235128
doi: 10.1371/journal.pone.0028512
Yelwa AA, Mainasara AS, Akuyam SA, Adamu BI, Umar ZU, Abubakar SD, Muhammad Y, Gamde SM, Abdulazziz A. Evaluation of serum sex hormones and CD4 + count among HIV patients on HAART, HAART naive patients and apparently healthy subjects in Sokoto, Nigeria. 2020.
Gomes AR, Souteiro P, Silva CG, Sousa-Pinto B, Almeida F, Sarmento A, Carvalho D, Freitas P. Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy. BMC Infect Dis. 2016;16(1):1–7.
doi: 10.1186/s12879-016-1892-5
Ezeugwunne I, Onyenekwe C, Ahaneku J, Ifeanyichukwu M, Meludu S, Onwurah O, Osuji F. Serum hormonal levels in HIV/AIDS infected male subjects on antiretroviral therapy (ART) in Nnewi, Nigeria. Int J Biol Chem Sci. 2012;6(4):1409–18.
Dejucq N, Jégou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65(2):208–31.
pubmed: 11381100
pmcid: 99025
doi: 10.1128/MMBR.65.2.208-231.2001
Cotter AG, Powderly WG. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. Best Pract Res Clin Endocrinol Metab. 2011;25(3):501–15.
pubmed: 21663843
doi: 10.1016/j.beem.2010.11.003
Wong N, Levy M, Stephenson I. Hypogonadism in the HIV-infected man. Curr Treat Options Infect Dis. 2017;9(1):104–16.
pubmed: 28344518
pmcid: 5346114
doi: 10.1007/s40506-017-0110-3
Meinhardt U, Mullis PE. The essential role of the aromatase/p450arom. In: Seminars in reproductive medicine: 2002: Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New… 7–284.
Richardson D, Goldmeier D, Frize G, Lamba H, De Souza C, Kocsis A, Scullard G. Letrozole versus testosterone. A single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised estradiol levels. J Sex Med. 2007;4(2):502–8.
pubmed: 17367446
doi: 10.1111/j.1743-6109.2007.00451.x
Ezeugwunne PI, Ogbodo CE, Analike AR, Obi-Ezeani NC, Onuora JI, Oguaka NV, Amah KU, Ugwu CM, Onyenekwe CC, Ahaneku EJ. Serum Reproductive hormone levels in male symptomatic HIV/AIDS patients on antiretroviral therapy negative to Malaria parasite in Nnewi, Anambra State, Nigeria. Asian J Med Sci. 2019;10(3):44–9.
doi: 10.3126/ajms.v10i3.22505
Tripathy SK, Agrawala RK, Baliarsinha AK. Endocrine alterations in HIV-infected patients. Indian J Endocrinol Metabol. 2015;19(1):143.
doi: 10.4103/2230-8210.146870
Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR. A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre-and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDs. 2005;19(10):655–71.
pubmed: 16232050
doi: 10.1089/apc.2005.19.655
Santi D, Spaggiari G, Vena W, Pizzocaro A, Maggi M, Rochira V, Corona G. The prevalence of hypogonadism and the effectiveness of androgen administration on body composition in HIV-infected men: a meta-analysis. Cells. 2021;10(8):2067.
pubmed: 34440836
pmcid: 8392149
doi: 10.3390/cells10082067
De Paepe ME, Vuletin JC, Lee MH, Rojas-Corona RR, Waxman M. Testicular atrophy in homosexual AIDS patients: an immune-mediated phenomenon? Hum Pathol. 1989;20(6):572–8.
pubmed: 2656498
doi: 10.1016/0046-8177(89)90246-3
Rochira V, Guaraldi G. Hypogonadism in the HIV-infected man. Endocrinol Metabolism Clin. 2014;43(3):709–30.
doi: 10.1016/j.ecl.2014.06.005
Ashby J, Goldmeier D, Sadeghi-Nejad H. Hypogonadism in human immunodeficiency virus-positive men. Korean J Urol. 2014;55(1):9–16.
pubmed: 24466391
pmcid: 3897637
doi: 10.4111/kju.2014.55.1.9
Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000;31(5):1240–4.
pubmed: 11073758
doi: 10.1086/317457
Wunder D, Fux CA, Bersinger NA, Mueller N, Hirschel B, Cavassini M, Elzi L, Schmid P, Bernasconi E, Mueller B. Androgen and gonadotropin patterns differ in HIV-1‐infected men who develop lipoatrophy during antiretroviral therapy: a case–control study. HIV Med. 2008;9(6):427–32.
pubmed: 18459947
doi: 10.1111/j.1468-1293.2008.00578.x
Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM, Team ACTGPAS. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metabolism. 2007;92(3):1049–57.
doi: 10.1210/jc.2006-2060
Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1988;84(3):611–6.
pubmed: 3348269
doi: 10.1016/0002-9343(88)90144-1
De Vincentis S, Decaroli MC, Fanelli F, Diazzi C, Mezzullo M, Morini F, Bertani D, Milic J, Carli F, Cuomo G. Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV. Eur J Endocrinol. 2021;184(1):107–22.
pubmed: 33112262
doi: 10.1530/EJE-20-0855
Rochira V, Diazzi C, Santi D, Brigante G, Ansaloni A, Decaroli MC, De Vincentis S, Stentarelli C, Zona S, Guaraldi G. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology. 2015;3(2):298–308.
pubmed: 25704864
doi: 10.1111/andr.310
Guaraldi G, Rockwood K. Geriatric-HIV medicine is born. In., vol. 65: Oxford University Press US; 2017: 507–509.
Shah K, Hilton TN, Myers L, Pinto JF, Luque AE, Hall WJ. A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60(3):545–9.
pubmed: 22315957
pmcid: 3302930
doi: 10.1111/j.1532-5415.2011.03819.x
Jasuja GK, Travison TG, Davda M, Murabito JM, Basaria S, Zhang A, Kushnir MM, Rockwood AL, Meikle W, Pencina MJ. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. Journals Gerontol Ser A: Biomedical Sci Med Sci. 2013;68(6):733–40.
doi: 10.1093/gerona/gls216
Grossmann M, Matsumoto AM. A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metabolism. 2017;102(3):1067–75.
doi: 10.1210/jc.2016-3580
Fernandez CJ, Chacko EC, Pappachan JM. Male obesity-related secondary hypogonadism–pathophysiology, clinical implications and management. Eur Endocrinol. 2019;15(2):83.
pubmed: 31616498
pmcid: 6785957
Kimambo SJ. 252 Acceptance of and adherence to anti-retroviral therapy in Tanzania: the influence of lipodystrophy and of traditional medicine. JAIDS J Acquir Immune Defic Syndr 2009, 51.
Peltzer K, Preez NF-d, Ramlagan S, Fomundam H. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008;8:1–14.
doi: 10.1186/1471-2458-8-255
Liwa A, Roediger R, Jaka H, Bougaila A, Smart L, Langwick S, Peck R. Herbal and alternative medicine use in Tanzanian adults admitted with hypertension-related diseases: a mixed-methods study. Int J Hypertens 2017, 2017.
Henke O, Bruchhausen W, Massawe A. Use of Herbal Medicine is Associated with Late-Stage Presentation in Tanzanian patients with Cancer: a Survey to assess the utilization of and reasons for the Use of Herbal Medicine. JCO Global Oncol. 2022;8:e2200069.
doi: 10.1200/GO.22.00069
Lunyera J, Wang D, Maro V, Karia F, Boyd D, Omolo J, Patel UD, Stanifer JW. Comprehensive kidney Disease Assessment for risk factors e, knowledge, study A: traditional medicine practices among community members with diabetes mellitus in Northern Tanzania: an ethnomedical survey. BMC Complement Altern Med. 2016;16:1–12.
doi: 10.1186/s12906-016-1262-2
Tabuti JR. Herbal medicines used in the treatment of malaria in Budiope County, Uganda. J Ethnopharmacol. 2008;116(1):33–42.
pubmed: 18054454
doi: 10.1016/j.jep.2007.10.036
Kyarimpa C, Nagawa CB, Omara T, Odongo S, Ssebugere P, Lugasi SO, Gumula I. Medicinal plants used in the management of sexual dysfunction, infertility and improving virility in the East African Community: a systematic review. Evidence-Based Complementary and Alternative Medicine 2023, 2023.
Leisegang K, Finelli R. Alternative medicine and herbal remedies in the treatment of erectile dysfunction: a systematic review. Arab J Urol. 2021;19(3):323–39.
pubmed: 34552783
pmcid: 8451697
doi: 10.1080/2090598X.2021.1926753
Roozbeh N, Rostami S, Abdi F. A review on herbal medicine with fertility and infertility characteristics in males. Iran J Obstet Gynecol Infertility. 2016;19(13):18–32.
World Health Organization. WHO Global report on traditional medicine and complementary medicine 2019. http://www.whoint/publications/i/item/978924151536 .
De Vincentis S, Decaroli MC, Fanelli F, Diazzi C, Mezzullo M, Tartaro G, Tagliavini S, De Santis MC, Roli L, Milic J. Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and chemiluminescent immunoassay for sex steroids assay. Aging Male. 2022;25(1):41–53.
pubmed: 35318882
doi: 10.1080/13685538.2022.2039116
Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M. Adult-and late-onset male hypogonadism: the clinical practice guidelines of the Italian society of andrology and sexual medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Investig. 2022;45(12):2385–403.
doi: 10.1007/s40618-022-01859-7
Moreno-Pérez O, Escoín C, Serna-Candel C, Portilla J, Boix V, Alfayate R, González-Sánchez V, Mauri M, Sánchez-Payá J, Picó A. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males. J Sex Med. 2010;7(8):2873–83.
pubmed: 20626606
doi: 10.1111/j.1743-6109.2010.01886.x